AACAP Physician Scientist Program in Substance Use
AACAP 药物使用医师科学家计划
基本信息
- 批准号:10412061
- 负责人:
- 金额:$ 177.18万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-01-01 至 2025-05-31
- 项目状态:未结题
- 来源:
- 关键词:AcademyAddressAdolescenceAdolescentAdolescent PsychiatryAdultAmericanAwardChildChild PsychiatryChildhoodClinical ResearchCountryDevelopmentDiseaseFundingHomeMental disordersMentorsMorbidity - disease ratePhysiciansProgram DevelopmentPsyche structurePsychiatristPsychopathologyResearchResearch PersonnelResearch TrainingResourcesSECTM1 geneScientistStructureSubstance Use DisorderTrainingTranslational ResearchWorkaddictionadolescent substance usecareercareer developmentdisorder preventionmeetingsmortalityprogramsresearch to practicesubstance usesuccesstraining opportunity
项目摘要
PROJECT SUMMARY/ABSTRACT
This renewal application from the American Academy of Child and Adolescent Psychiatry (AACAP) requests
support for the continuation of the AACAP Physician Scientist Program in Substance Use. Most mental and
substance use disorders emerge during childhood and adolescence, but they are rarely recognized or addressed
until adulthood. With specialized training in developmental psychopathology, child and adolescent psychiatrists
are ideally suited to address these disorders before adulthood to reduce associated morbidity and mortality.
While it is clearly recognized that substance use complicates the course of mental disorders, few child and
adolescent psychiatrists receive specialized training to address substance use disorders, and exceedingly few
pursue careers in research to advance substance use disorder prevention and treatment. Established in 1998,
the AACAP Physician Scientist Program in Substance Use addresses this critical shortage by delivering a highly
structured clinical research training and career development program for outstanding child and adolescent
psychiatrists with the potential to make significant impacts on adolescent substance use disorder prevention and
treatment. Since its inception, the program has successfully cultivated the careers of 24 child and adolescent
psychiatrist physician-scientists. Twenty-three of the 24 scholars have gone on to establish or are well on their
way to establishing careers in substance use-related research. AACAP remains an ideal institutional home for
the K12 given its strong institutional commitment, ample resources, and membership that includes more than
95% of child and adolescent psychiatrists in the country, including all current and former K12 scholars. AACAP
has pledged its continued commitment and support of scholars’ career development if the renewal is awarded.
Additionally, K12 scholars’ research presentations at the AACAP Annual Meetings facilitate and accelerate the
pace of translation from research to practice, clearly impacting the field. The program is making important
progress, but more work is needed, as fewer than 2% of child and adolescent psychiatrists are significantly
involved in research, and even fewer have established careers in substance use-related research. This renewal
application proposes to build upon the program’s success to date by addressing the following aims. Aim 1: To
increase the number of independently funded child and adolescent psychiatrist addiction researchers. Aim 2: To
expand the network of senior mentors, academic centers, and addiction research training opportunities for K12
scholars and other early career investigators.
项目总结/摘要
美国儿童和青少年精神病学学会(AACAP)的这份更新申请要求
支持继续AACAP药物使用医师科学家计划。最精神和
物质使用障碍出现在儿童和青少年时期,但很少得到承认或解决
直到成年在发展精神病理学方面受过专门训练的儿童和青少年精神病学家
非常适合在成年前治疗这些疾病,以减少相关的发病率和死亡率。
虽然人们清楚地认识到,物质的使用使精神障碍的过程复杂化,但很少有儿童和
青少年精神科医生接受专门培训,以解决物质使用障碍,
从事研究工作,以促进物质使用障碍的预防和治疗。成立于1998年,
AACAP药物使用医师科学家计划通过提供一个高度
为优秀儿童和青少年提供结构化的临床研究培训和职业发展计划
有可能对青少年物质使用障碍预防产生重大影响的精神科医生,
治疗自成立以来,该计划已成功培养了24名儿童和青少年的职业生涯
精神病学家和科学家24位学者中有23位已经建立或正在建立他们的
在物质使用相关研究中建立职业生涯的方法。AACAP仍然是一个理想的机构家园,
K12拥有强大的机构承诺、充足的资源和成员,
全国95%的儿童和青少年精神科医生,包括所有现任和前任K12学者。AACAP
并承诺如获续约,会继续致力支持学者的事业发展。
此外,K12学者在AACAP年会上的研究报告促进和加速了
从研究到实践的转化速度,明显影响了该领域。该计划使重要的
进展,但还需要更多的工作,因为只有不到2%的儿童和青少年精神科医生
参与研究的人很少,在与药物使用有关的研究中建立职业生涯的人就更少了。此续订
申请书提出,通过实现以下目标,在该方案迄今取得的成功基础上再接再厉。目标1:
增加独立资助的儿童和青少年精神病成瘾研究人员的数量。目标2:
扩大K12的高级导师网络、学术中心和成瘾研究培训机会
学者和其他早期职业调查员。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kevin M Gray其他文献
Nicotine Therapy Sampling to Induce Quit Attempts Among Smokers Unmotivated to Quit
尼古丁治疗取样以诱导无戒烟动机的吸烟者尝试戒烟
- DOI:
- 发表时间:
2016 - 期刊:
- 影响因子:0
- 作者:
M. Carpenter;John R. Hughes;Kevin M Gray;A. Wahlquist;M. Saladin;A. Alberg - 通讯作者:
A. Alberg
Kevin M Gray的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kevin M Gray', 18)}}的其他基金
A Proof-of-Concept Trial of N-Acetylcysteine for Adolescent Alcohol Use Disorder
N-乙酰半胱氨酸治疗青少年酒精使用障碍的概念验证试验
- 批准号:
10480914 - 财政年份:2018
- 资助金额:
$ 177.18万 - 项目类别:
A Proof-of-Concept Trial of N-Acetylcysteine for Adolescent Alcohol Use Disorder
N-乙酰半胱氨酸治疗青少年酒精使用障碍的概念验证试验
- 批准号:
10241372 - 财政年份:2018
- 资助金额:
$ 177.18万 - 项目类别:
A Proof-of-Concept Trial of N-Acetylcysteine for Adolescent Alcohol Use Disorder
N-乙酰半胱氨酸治疗青少年酒精使用障碍的概念验证试验
- 批准号:
9789787 - 财政年份:2018
- 资助金额:
$ 177.18万 - 项目类别:
13/21 ABCD-USA CONSORTIUM: RESEARCH PROJECT SITE AT MUSC
13/21 ABCD-美国联盟:MUSC 研究项目现场
- 批准号:
10596593 - 财政年份:2017
- 资助金额:
$ 177.18万 - 项目类别:
N-Acetylcysteine and Contingency Management for Youth Cannabis Use Disorder
N-乙酰半胱氨酸和青少年大麻使用障碍的应急管理
- 批准号:
9156301 - 财政年份:2017
- 资助金额:
$ 177.18万 - 项目类别:
N-Acetylcysteine and Contingency Management for Youth Cannabis Use Disorder
N-乙酰半胱氨酸和青少年大麻使用障碍的应急管理
- 批准号:
10087909 - 财政年份:2017
- 资助金额:
$ 177.18万 - 项目类别:
13/21 ABCD-USA CONSORTIUM: RESEARCH PROJECT SITE AT MUSC
13/21 ABCD-美国联盟:MUSC 研究项目现场
- 批准号:
9981294 - 财政年份:2017
- 资助金额:
$ 177.18万 - 项目类别:
13/21 ABCD-USA CONSORTIUM: RESEARCH PROJECT SITE AT MUSC
13/21 ABCD-美国联盟:MUSC 研究项目现场
- 批准号:
10379329 - 财政年份:2017
- 资助金额:
$ 177.18万 - 项目类别:
Advancing Varenicline as a Treatment for Cannabis Use Disorder
推进伐尼克兰治疗大麻使用障碍
- 批准号:
9249775 - 财政年份:2016
- 资助金额:
$ 177.18万 - 项目类别:
Advancing Varenicline as a Treatment for Cannabis Use Disorder
推进伐尼克兰治疗大麻使用障碍
- 批准号:
10202536 - 财政年份:2016
- 资助金额:
$ 177.18万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 177.18万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 177.18万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 177.18万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 177.18万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 177.18万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 177.18万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 177.18万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 177.18万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 177.18万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 177.18万 - 项目类别:
Research Grant














{{item.name}}会员




